PYXS

Pyxis Oncology (PYXS)

Pyxis Oncology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PYXS

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	21 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PYXS	Pyxis Oncology Inc
2024/05/14	20 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/05/14	20 : 30	GlobeNewswire Inc.	Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024	NASDAQ:PYXS	Pyxis Oncology Inc
2024/05/09	20 : 30	GlobeNewswire Inc.	Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/29	05 : 30	GlobeNewswire Inc.	Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/27	20 : 30	GlobeNewswire Inc.	Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/21	20 : 30	GlobeNewswire Inc.	Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/13	21 : 00	GlobeNewswire Inc.	Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/09	06 : 03	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/08	06 : 30	GlobeNewswire Inc.	Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024	NASDAQ:PYXS	Pyxis Oncology Inc
2024/03/06	06 : 45	GlobeNewswire Inc.	Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting	NASDAQ:PYXS	Pyxis Oncology Inc
2024/02/28	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2024/02/27	22 : 00	GlobeNewswire Inc.	Pyxis Oncology Announces $50 Million Private Placement	NASDAQ:PYXS	Pyxis Oncology Inc
2023/12/30	06 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/12/30	06 : 30	GlobeNewswire Inc.	Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PYXS	Pyxis Oncology Inc
2023/12/07	06 : 50	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/12/01	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/11/28	21 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2023/11/28	21 : 00	GlobeNewswire Inc.	Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer	NASDAQ:PYXS	Pyxis Oncology Inc
2023/11/18	06 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/11/08	06 : 46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PYXS	Pyxis Oncology Inc
2023/11/08	06 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PYXS	Pyxis Oncology Inc
2023/11/08	06 : 30	GlobeNewswire Inc.	Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update	NASDAQ:PYXS	Pyxis Oncology Inc
2023/10/28	05 : 34	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PYXS	Pyxis Oncology Inc
2023/09/29	05 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/09/28	07 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/09/28	07 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/09/27	22 : 18	GlobeNewswire Inc.	Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023	NASDAQ:PYXS	Pyxis Oncology Inc
2023/09/26	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc
2023/09/26	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PYXS	Pyxis Oncology Inc